Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05404139 |
Title | Duration of Enzalutamide and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT) |
Recruitment | Active, not recruiting |
Gender | male |
Phase | Phase II |
Variant Requirements | No |
Sponsors | University Health Network, Toronto |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | CAN |